Contineum Therapeutics, Inc. (CTNM): Revenue

Annual figures by period end, from SEC filings.

$0
Year ended 2024-12-31
$50.00M2023-12-31: $50.00M2024-12-31: $0$0
2023-12-31 Revenue (USD) 2024-12-31
Period endedRevenueChange YoYSource filing
2024-12-31$0-100.0%2025-03-06, From 2024-01-01
2023-12-31$50.00Mn/a2025-03-06, From 2023-01-01